Amedisys Price to Free Cash Flow Ratio 2010-2024 | AMED
Historical price to free cash flow ratio values for Amedisys (AMED) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Amedisys Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-05-02 |
92.43 |
|
30.74 |
| 2024-03-31 |
92.16 |
$3.01 |
30.65 |
| 2023-12-31 |
95.06 |
$4.04 |
23.53 |
| 2023-09-30 |
93.40 |
$3.42 |
27.28 |
| 2023-06-30 |
91.44 |
$3.32 |
27.58 |
| 2023-03-31 |
73.55 |
$3.19 |
23.05 |
| 2022-12-31 |
83.54 |
$3.90 |
21.45 |
| 2022-09-30 |
96.79 |
$2.81 |
34.46 |
| 2022-06-30 |
105.12 |
$5.09 |
20.64 |
| 2022-03-31 |
172.29 |
$5.42 |
31.79 |
| 2021-12-31 |
161.88 |
$5.54 |
29.21 |
| 2021-09-30 |
149.10 |
$7.34 |
20.30 |
| 2021-06-30 |
244.93 |
$7.98 |
30.69 |
| 2021-03-31 |
264.79 |
$9.97 |
26.56 |
| 2020-12-31 |
293.33 |
$8.53 |
34.40 |
| 2020-09-30 |
236.43 |
$8.87 |
26.67 |
| 2020-06-30 |
198.54 |
$7.73 |
25.69 |
| 2020-03-31 |
183.54 |
$5.47 |
33.58 |
| 2019-12-31 |
166.92 |
$5.90 |
28.28 |
| 2019-09-30 |
131.01 |
$5.43 |
24.14 |
| 2019-06-30 |
121.41 |
$7.69 |
15.80 |
| 2019-03-31 |
123.26 |
$7.05 |
17.48 |
| 2018-12-31 |
117.11 |
$7.39 |
15.84 |
| 2018-09-30 |
124.96 |
$5.87 |
21.28 |
| 2018-03-31 |
60.34 |
$3.25 |
18.55 |
| 2017-12-31 |
52.71 |
$2.80 |
18.86 |
| 2017-09-30 |
55.96 |
$0.65 |
85.97 |
| 2017-06-30 |
62.81 |
$2.41 |
26.06 |
| 2017-03-31 |
51.09 |
$1.54 |
33.13 |
| 2016-12-31 |
42.63 |
$1.22 |
34.92 |
| 2018-06-30 |
85.46 |
$2.61 |
32.68 |
| 2016-09-30 |
47.44 |
$1.75 |
27.10 |
| 2016-06-30 |
50.48 |
$2.49 |
20.24 |
| 2016-03-31 |
48.34 |
$3.01 |
16.07 |
| 2015-12-31 |
39.32 |
$3.22 |
12.21 |
| 2015-09-30 |
37.97 |
$2.14 |
17.76 |
| 2015-06-30 |
39.73 |
$2.08 |
19.12 |
| 2015-03-31 |
26.78 |
$-1.62 |
0.00 |
| 2014-12-31 |
29.35 |
$-2.37 |
0.00 |
| 2014-09-30 |
20.17 |
$-2.51 |
0.00 |
| 2014-06-30 |
16.74 |
$-2.70 |
0.00 |
| 2014-03-31 |
14.89 |
$0.90 |
16.61 |
| 2013-12-31 |
14.63 |
$1.99 |
7.35 |
| 2013-09-30 |
17.21 |
$2.07 |
8.32 |
| 2013-06-30 |
11.60 |
$1.80 |
6.45 |
| 2013-03-31 |
11.12 |
$1.43 |
7.76 |
| 2012-12-31 |
11.31 |
$0.74 |
15.24 |
| 2012-09-30 |
13.82 |
$1.83 |
7.54 |
| 2012-06-30 |
12.45 |
$2.06 |
6.04 |
| 2012-03-31 |
14.46 |
$-1.65 |
0.00 |
| 2011-12-31 |
10.91 |
$-1.42 |
0.00 |
| 2011-09-30 |
14.82 |
$-1.32 |
0.00 |
| 2011-06-30 |
26.63 |
$-0.38 |
0.00 |
| 2010-12-31 |
33.50 |
$5.09 |
6.58 |
| 2010-09-30 |
23.80 |
$11.20 |
2.13 |
| 2010-06-30 |
43.98 |
$11.28 |
3.90 |
| 2010-03-31 |
55.22 |
$12.53 |
4.41 |
| 2009-12-31 |
48.60 |
$12.86 |
3.78 |
| 2011-03-31 |
35.00 |
$8.22 |
4.26 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$3.003B |
$2.236B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
